XML 78 R48.htm IDEA: XBRL DOCUMENT v3.25.1
Acquisition of Apexigen - Additional Information (Details) - USD ($)
12 Months Ended
Aug. 23, 2023
Dec. 31, 2024
Dec. 31, 2023
Apexigen, Inc.      
Business Acquisition [Line Items]      
Right to receive shares conversion 0.1725    
Stock issued 4,344,435    
Issuance costs, incurred   $ 0  
Fair value of consideration transferred $ 10,000,000    
Consideration transferred amount 10,700,000    
Net loss     $ 97,800,000
Replacement Options and RSU | Apexigen, Inc.      
Business Acquisition [Line Items]      
Fair value of consideration transferred 100,000    
Replacement Warrants | Apexigen, Inc.      
Business Acquisition [Line Items]      
Fair value of consideration transferred $ 600,000    
General and Administrative      
Business Acquisition [Line Items]      
Transaction related costs, incurred     $ 1,700,000